Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ovarian Neoplasms 104 Breast Neoplasms 76 Fallopian Tube Neoplasms 47 Multiple Myeloma 32 Carcinoma, Ovarian Epithelial 27 Neoplasms 23 Lymphoma 16 Sarcoma 13 Triple Negative Breast Neoplasms 12 Recurrence 12 Neoplasm Metastasis 12 Lymphoma, Large B-Cell, Diffuse 10 Lymphoma, Non-Hodgkin 8 Hodgkin Disease 8 Neoplasms, Plasma Cell 6 Prostatic Neoplasms 5 Burkitt Lymphoma 5 Solid Tumors 4 Sarcoma, Kaposi 4 Sarcoma, Ewing 4 Pancreatic Neoplasms 4 Lymphoma, T-Cell, Peripheral 4 Lymphoma, Mantle-Cell 4 Leiomyosarcoma 4 Endometrial Neoplasms 4 Carcinoma 4 Breast Neoplasms, Male 4 Uterine Cervical Neoplasms 3 Rhabdomyosarcoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3

Interventions

Fluorouracil 219 Leucovorin 202 Oxaliplatin 192 Irinotecan 150 Bevacizumab 110 Capecitabine 94 Cetuximab 90 Folfox protocol 54 Chemotherapy, Adjuvant 36 Panitumumab 30 Colonoscopy 30 pembrolizumab 23 Drug Therapy 23 Nivolumab 22 Magnetic Resonance Spectroscopy 22 Gemcitabine 21 Blood Specimen Collection 20 Radiotherapy 19 Floxuridine 19 Biopsy 19 Neoadjuvant Therapy 18 Laparoscopy 18 IFL protocol 18 Early Intervention, Educational 18 Celecoxib 18 Surveys and Questionnaires 17 Surgical Procedures, Operative 16 Immunohistochemistry 16 Exercise 16 trifluridine tipiracil drug combination 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Colonic Neoplasms × liposomal doxorubicin × Clear all

NCT01464593 2022-10-13

ABLATE

Imunon

Phase 2 Terminated

2 enrolled 5 charts

Gastrointestinal

Colonic Neoplasms, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡